ARI-0001, YESCARTA 0.4 – 2 x 10e8 cells dispersion for infusion
HO161
Phase 2 small_molecule active
Quick answer
ARI-0001, YESCARTA 0.4 – 2 x 10e8 cells dispersion for infusion for relapsed/refractory Non-Hodgkin Lymphoma is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- relapsed/refractory Non-Hodgkin Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active